A Retrospective Analysis of the Outcome of Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Refractory to a Platinum-based Chemotherapy
- 1 September 2005
- journal article
- research article
- Published by Elsevier in Clinical Oncology
- Vol. 17 (6), 418-424
- https://doi.org/10.1016/j.clon.2005.02.014
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive reviewCancer Treatment Reviews, 2003
- Treatment of Metastatic Head and Neck Cancer: Chemotherapy and Novel AgentsPublished by Springer Nature ,2002
- Interstitial low-dose-rate brachytherapy as a salvage treatment for recurrent head-and-neck cancers: long-term resultsInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Recurrent Head and Neck Cancer: Retreatment of Previously Irradiated Areas with Combined Chemotherapy and Radiation Therapy—Results of a Prospective StudyRadiology, 2000
- Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients.Journal of Clinical Oncology, 1998
- Cancer incidence and mortality in the European Union: Cancer registry data and estimates of national incidence for 1990European Journal Of Cancer, 1997
- Chemotherapy for symptom control in recurrent squamous cell carcinoma of the head and neckAnnals of Oncology, 1997
- Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neckAnnals of Oncology, 1994
- Head and Neck CancerNew England Journal of Medicine, 1993
- SURVIVAL AFTER "PALLIATIVE" CYTOTOXIC CHEMOTHERAPY FOR HEAD-AND-NECK CANCERThe Lancet, 1983